Tomohito Hagi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Mass Spectrometry

Artificial Intelligence

Prognostic Factors

Top Venues

Cancer medicine

Japanese journal of clinical oncology

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Tomohito Hagi, Tomoki Nakamura, Hiroto Yuasa, Katsunori Uchida, Kunihiro Asanuma, Akihiro Sudo, Tetsushi Wakabayahsi, Kento Morita
Prediction of prognosis using artificial intelligence-based histopathological image analysis in patients with soft tissue sarcomas. Cancer medicine 13 (10) (2024)
Tomohito Hagi, Tomoki Nakamura, Hiroto Yuasa, Katsunori Uchida, Kunihiro Asanuma, Akihiro Sudo, Tetsushi Wakabayahsi, Kento Morita
Prediction of prognosis using artificial intelligence-based histopathological image analysis in patients with soft tissue sarcomas. Cancer medicine 13 (10) (2024)
Tomohito Hagi, Tomoki Nakamura, Hiroto Yuasa, Katsunori Uchida, Kunihiro Asanuma, Akihiro Sudo, Tetsushi Wakabayahsi, Kento Morita
Prediction of prognosis using artificial intelligence-based histopathological image analysis in patients with soft tissue sarcomas. Cancer medicine 13 (10) (2024)
Tomohito Hagi, Tomoki Nakamura, Akihito Nagano, Hiroshi Koike, Kenji Yamada, Hisaki Aiba, Nasa Fujihara, Junji Wasa, Kunihiro Asanuma, Eiji Kozawa, Daisuke Ishimura, Katsuhisa Kawanami, Yuya Izubuchi, Yoji Shido, Akihiro Sudo, Yoshihiro Nishida
Clinical outcome in patients who underwent amputation due to extremity soft tissue sarcoma: Tokai Musculoskeletal Oncology Consortium study. Japanese journal of clinical oncology (2021)
Tomoki Nakamura, Kunihiro Asanuma, Tomohito Hagi, Akihiro Sudo
Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan. Drug design, development and therapy 14 (2020)